Temat: "Biomarkers, Tumor" - OpacWWW

Skocz do pozycji: 41.

Tytuł:: BNIPL is a promising biomarker of laryngeal cancer: novel insights from bioinformatics analysis and experimental validation.
Autorzy:: Wang R; Department of Otolaryngology Head and Neck Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, No. 99, Longcheng Street, Taiyuan City, Shanxi Province, 030032, China.; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei Province, 430030, China.
Gao Y; Department of Otolaryngology Head and Neck Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, No. 99, Longcheng Street, Taiyuan City, Shanxi Province, 030032, China.; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei Province, 430030, China.
Wen S; Department of Otolaryngology Head and Neck Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, No. 99, Longcheng Street, Taiyuan City, Shanxi Province, 030032, China. .; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei Province, 430030, China. .
Guo X; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei Province, 430030, China.; Department of Head Neck and Breast Oncology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan City, Shanxi Province, 030032, China.; Pokaż więcej
Źródło:: BMC medical genomics [BMC Med Genomics] 2024 Feb 01; Vol. 17 (1), pp. 45. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Gene Expression Profiling*
Laryngeal Neoplasms*/genetics
Humans ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Protein Interaction Maps/genetics ; Computational Biology ; Adaptor Proteins, Signal Transducing/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 42.

Tytuł:: A gene expression-based classifier for HER2-low breast cancer.
Autorzy:: Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Pizzamiglio S; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. .
Ciniselli CM; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Duroni V; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Cappelletti V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
De Cecco L; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
De Marco C; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Silvestri M; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
De Santis MC; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Breast Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Vingiani A; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Breast Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Paolini B; Department of Pathology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Orlandi R; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Iorio MV; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Pruneri G; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Breast Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Verderio P; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 01; Vol. 14 (1), pp. 2628. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/genetics
Humans ; Female ; Receptor, ErbB-2/metabolism ; Genes, erbB-2 ; Immunohistochemistry ; Gene Expression ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 43.

Tytuł:: Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression.
Autorzy:: Tozbikian G; From the Department of Pathology, The Ohio State University, Wexner Medical Center, Columbus (Tozbikian).
Krishnamurthy S; the Department of Pathology (Krishnamurthy), The University of Texas MD Anderson Cancer Center, Houston.
Bui MM; the Department of Pathology, Moffitt Cancer Center & Research Institute, Tampa, Florida (Bui).
Feldman M; the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Feldman).
Hicks DG; the Department of Pathology, University of Rochester Medical Center, Rochester, New York (Hicks).
Jaffer S; the Department of Pathology, Mount Sinai Medical Center, New York, New York (Jaffer).
Khoury T; the Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York (Khoury).
Wei S; the Department of Pathology, University of Kansas Medical Center; Kansas City (Wei).
Wen H; the Department of Pathology, Memorial Sloan Kettering Cancer Center; New York, New York (Wen).
Pohlmann P; the Department of Breast Medical Oncology (Pohlmann), The University of Texas MD Anderson Cancer Center, Houston.; Pokaż więcej
Źródło:: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Feb 01; Vol. 148 (2), pp. 242-255.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Humans ; Female ; In Situ Hybridization, Fluorescence ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Gene Amplification ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 44.

Tytuł:: A Novel Preclinical In Vitro 3D Model of Oral Carcinogenesis for Biomarker Discovery and Drug Testing.
Autorzy:: Chitturi Suryaprakash RT; UWA Dental School, The University of Western Australia, Nedlands, WA 6009, Australia.
Shearston K; UWA Dental School, The University of Western Australia, Nedlands, WA 6009, Australia.
Farah CS; Australian Centre for Oral Oncology Research and Education, Nedlands, WA 6009, Australia.
Fox SA; UWA Dental School, The University of Western Australia, Nedlands, WA 6009, Australia.; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia.
Iqbal MM; Genomics WA, Harry Perkins Institute of Medical Research, Telethon Kids Institute, The University of Western Australia, Nedlands, WA 6009, Australia.
Kadolsky U; Genomics WA, Harry Perkins Institute of Medical Research, Telethon Kids Institute, The University of Western Australia, Nedlands, WA 6009, Australia.
Zhong X; Genomics WA, Harry Perkins Institute of Medical Research, Telethon Kids Institute, The University of Western Australia, Nedlands, WA 6009, Australia.
Saxena A; Genomics WA, Harry Perkins Institute of Medical Research, Telethon Kids Institute, The University of Western Australia, Nedlands, WA 6009, Australia.
Kujan O; UWA Dental School, The University of Western Australia, Nedlands, WA 6009, Australia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 17; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 17.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinogenesis*/drug effects
Carcinogenesis*/metabolism
Mouth Neoplasms*/chemically induced
Mouth Neoplasms*/metabolism
Cell Culture Techniques, Three Dimensional*
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Spheroids, Cellular*
Antineoplastic Agents*/pharmacology
Humans ; Carcinogens/pharmacology ; Squamous Cell Carcinoma of Head and Neck ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Drug Screening Assays, Antitumor ; Tumor Cells, Cultured

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 45.

Tytuł:: An Epidemiological Systematic Review with Meta-Analysis on Biomarker Role of Circulating MicroRNAs in Breast Cancer Incidence.
Autorzy:: Padroni L; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Via Santena 7, 10126 Turin, Italy.
De Marco L; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Via Santena 7, 10126 Turin, Italy.
Dansero L; Centre for Biostatistics, Epidemiology and Public Health (C-BEPH), Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Fiano V; Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Milani L; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Via Santena 7, 10126 Turin, Italy.
Vasapolli P; Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Manfredi L; Centre for Biostatistics, Epidemiology and Public Health (C-BEPH), Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Caini S; Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.
Agnoli C; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Ricceri F; Centre for Biostatistics, Epidemiology and Public Health (C-BEPH), Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.; Unit of Epidemiology, Regional Health Service ASL TO3, 10095 Grugliasco, Italy.
Sacerdote C; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Via Santena 7, 10126 Turin, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 15; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Biomarkers, Tumor*/analysis
Biomarkers, Tumor*/metabolism
Breast Neoplasms*/diagnosis
Breast Neoplasms*/epidemiology
Circulating MicroRNA*/analysis
Circulating MicroRNA*/metabolism
Female ; Humans ; Incidence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 46.

Tytuł:: Expression of Epithelial and Mesenchymal Markers in Plasmatic Extracellular Vesicles as a Diagnostic Tool for Neoplastic Processes.
Autorzy:: Alen BO; Molecular Biology Area, Department of Anatomical Pathology, Biomedical Research Institute A Coruña (INIBIC), University Hospital Complex A Coruña, 15006 A Coruña, Spain.
Estévez-Pérez LS; Molecular Biology Area, Department of Anatomical Pathology, Biomedical Research Institute A Coruña (INIBIC), University Hospital Complex A Coruña, 15006 A Coruña, Spain.
Otero Alén M; Santiago de Compostela Health Research Institute (IDIS), University Hospital Complex Santiago de Compostela, 15706 Santiago de Compostela, Spain.
Domínguez Hormaetxe S; Oncomatryx Biopharma, 48160 Derio, Spain.
Simón L; Oncomatryx Biopharma, 48160 Derio, Spain.
Concha Á; Molecular Biology Area, Department of Anatomical Pathology, Biomedical Research Institute A Coruña (INIBIC), University Hospital Complex A Coruña, 15006 A Coruña, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 10; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 10.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Extracellular Vesicles*/genetics
Extracellular Vesicles*/metabolism
Epithelial-Mesenchymal Transition*/genetics
Humans ; Exosomes ; Neoplastic Processes ; RNA/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 47.

Tytuł:: Metabolic pathways enriched according to ERG status are associated with biochemical recurrence in Hispanic/Latino patients with prostate cancer.
Autorzy:: Acosta-Vega NL; Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.; Programa de doctorado en Ciencias Biológicas, Pontificia Universidad Javeriana, Bogotá, DC, Colombia.
Varela R; Departamento de Urología, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.
Mesa JA; Departamento de Patología Oncológica, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.
Garai J; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Baddoo MC; Tulane University School of Medicine, New Orleans, Louisiana, USA.
Gómez-Gutiérrez A; Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, DC, Colombia.
Serrano-Gómez SJ; Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.
Lemus MN; Grupo de Apoyo y Seguimiento para la Investigación, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.
Serrano ML; Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.; Departamento de Química, Facultad de Ciencias, Universidad Nacional de Colombia, Bogotá, DC, Colombia.
Zabaleta J; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.; Department of Interdisciplinary Oncology, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Combita AL; Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.; Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, DC, Colombia.
Sanabria-Salas MC; Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología de Colombia, Bogotá, DC, Colombia.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (4), pp. 4306-4320. Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/metabolism
Male ; Humans ; Prognosis ; Prostatectomy ; Metabolic Networks and Pathways ; RNA/metabolism ; Neoplasm Recurrence, Local/genetics ; Transcriptional Regulator ERG/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 48.

Tytuł:: Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.
Autorzy:: Zheng K; Department of Urology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Hai Y; Department of Urology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Chen H; Department of Urology, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou, 215200, Jiangsu, China.
Zhang Y; Beijing University of Chinese Medicine East Hospital, Zaozhuang Hospital, Zaozhuang, 277000, Shandong, China.
Hu X; Department of Urology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. .
Ni K; Department of Urology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Apr 17; Vol. 22 (1), pp. 365. Date of Electronic Publication: 2024 Apr 17.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*
Humans ; Immunotherapy ; Biomarkers, Tumor ; Algorithms ; Cluster Analysis ; Tumor Microenvironment ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 49.

Tytuł:: DNA-based molecular classifiers for the profiling of gene expression signatures.
Autorzy:: Zhang L; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.; Department of Forensic Medicine, Chongqing Medical University, Chongqing, 400016, China.
Liu Q; Nuclear Medicine Department, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
Guo Y; Clinical Laboratory, Traditional Chinese Medicine Hospital Affiliated to Southwest Medical University, Luzhou, 646000, China.
Tian L; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Chen K; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Bai D; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Yu H; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Han X; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Luo W; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Feng T; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Deng S; Department of Forensic Medicine, Chongqing Medical University, Chongqing, 400016, China. .
Xie G; Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Apr 17; Vol. 22 (1), pp. 189. Date of Electronic Publication: 2024 Apr 17.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*
Liver Neoplasms*/genetics
Humans ; Transcriptome ; Gene Expression Profiling ; DNA ; Biomarkers, Tumor/metabolism ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 50.

Tytuł:: Prevalence of diverse colorectal polyps and risk factors for colorectal carcinoma in situ and neoplastic polyps.
Autorzy:: Li X; Department of Gastroenterology, Minhang Hospital, Fudan University, Shanghai, 201199, China.
Hu M; Department of General Medicine, Minhang Hospital, Fudan University, Shanghai, 201199, China.
Wang Z; Proprietary Trading Department, Huaan Securities Co., Ltd, Shanghai, 200120, China.
Liu M; Department of General Medicine, Minhang Hospital, Fudan University, Shanghai, 201199, China. liu_.
Chen Y; Department of Gastroenterology, Minhang Hospital, Fudan University, Shanghai, 201199, China. chenying_.; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Apr 17; Vol. 22 (1), pp. 361. Date of Electronic Publication: 2024 Apr 17.
Typ publikacji:: Journal Article
MeSH Terms:: Colonic Polyps*/pathology
Colorectal Neoplasms*/pathology
Adenoma*/pathology
Humans ; Prevalence ; Risk Factors ; Biomarkers, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 51.

Tytuł:: Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest.
Autorzy:: Liu HE; Vortex Biosciences, Inc, Pleasanton, CA, USA. .
Vuppalapaty M; Vortex Biosciences, Inc, Pleasanton, CA, USA.
Hoerner CR; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Bergstrom CP; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Comprehensive Cancer Center, Stanford University School of Medicine, Stanford, CA, USA.
Chiu M; Vortex Biosciences, Inc, Pleasanton, CA, USA.
Lemaire C; Vortex Biosciences, Inc, Pleasanton, CA, USA.
Che J; Vortex Biosciences, Inc, Pleasanton, CA, USA.
Kaur A; Vortex Biosciences, Inc, Pleasanton, CA, USA.
Dimmick A; Vortex Biosciences, Inc, Pleasanton, CA, USA.
Liu S; Vortex Biosciences, Inc, Pleasanton, CA, USA.
Metzner TJ; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Comprehensive Cancer Center, Stanford University School of Medicine, Stanford, CA, USA.
Araya M; Stanford Comprehensive Cancer Center, Stanford University School of Medicine, Stanford, CA, USA.
Crouse S; Vortex Biosciences, Inc, Pleasanton, CA, USA.
Sprenger-Haussels M; QIAGEN GmbH, Hilden, Germany.
Schlumpberger M; QIAGEN GmbH, Hilden, Germany.
Leppert JT; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Comprehensive Cancer Center, Stanford University School of Medicine, Stanford, CA, USA.
Hauch S; QIAGEN GmbH, Hilden, Germany. .
Sollier E; Vortex Biosciences, Inc, Pleasanton, CA, USA. .
Fan AC; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. .; Stanford Comprehensive Cancer Center, Stanford University School of Medicine, Stanford, CA, USA. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 16; Vol. 24 (1), pp. 482. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:: Journal Article
MeSH Terms:: Prostatic Neoplasms, Castration-Resistant*/drug therapy
Cell-Free Nucleic Acids*/therapeutic use
Exosomes*/genetics
Exosomes*/metabolism
Neoplastic Cells, Circulating*/pathology
Male ; Humans ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Prostate-Specific Antigen ; Prostate/pathology ; Protein Isoforms/genetics ; Biomarkers, Tumor/genetics ; Androgen Receptor Antagonists/therapeutic use ; RNA, Messenger/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 52.

Tytuł:: Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.
Autorzy:: Liu SS; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University; Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China, No 17, Yongwai Zheng Street, 330006, Nanchang, China.
Wan QS; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University; Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China, No 17, Yongwai Zheng Street, 330006, Nanchang, China.
Lv C; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University; Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China, No 17, Yongwai Zheng Street, 330006, Nanchang, China.
Wang JK; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University; Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China, No 17, Yongwai Zheng Street, 330006, Nanchang, China.
Jiang S; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University; Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China, No 17, Yongwai Zheng Street, 330006, Nanchang, China.
Cai D; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University; Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China, No 17, Yongwai Zheng Street, 330006, Nanchang, China.
Liu MS; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University; Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China, No 17, Yongwai Zheng Street, 330006, Nanchang, China.
Wang T; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University; Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China, No 17, Yongwai Zheng Street, 330006, Nanchang, China.
Zhang KH; Department of Gastroenterology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University; Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China, No 17, Yongwai Zheng Street, 330006, Nanchang, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 15; Vol. 24 (1), pp. 465. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Stomach Neoplasms*/diagnosis
Stomach Neoplasms*/genetics
Stomach Neoplasms*/metabolism
Humans ; Biomarkers, Tumor/metabolism ; Gene Expression Profiling ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Nuclear Factor 45 Protein/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 53.

Tytuł:: A case of pancreatic PEComa with prominent inflammatory cell infiltration: the inflammatory subtype is a distinct histologic group of PEComa.
Autorzy:: Tsukita H; Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, 1- 1-1 Hondo, Akita-shi, Akita, 010-8543, Japan.; Department of Pathology, Nihonkai General Hospital, Sakata, Japan.
Koyama K; Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, 1- 1-1 Hondo, Akita-shi, Akita, 010-8543, Japan. .
Ishinari T; Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, 1- 1-1 Hondo, Akita-shi, Akita, 010-8543, Japan.
Takahashi A; Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, 1- 1-1 Hondo, Akita-shi, Akita, 010-8543, Japan.; Department of Pathology, Nihonkai General Hospital, Sakata, Japan.
Miyabe K; Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, 1- 1-1 Hondo, Akita-shi, Akita, 010-8543, Japan.
Umakoshi M; Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, 1- 1-1 Hondo, Akita-shi, Akita, 010-8543, Japan.; Department of Pathology, Akita City Hospital, Akita, Japan.
Yoshida M; Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, 1- 1-1 Hondo, Akita-shi, Akita, 010-8543, Japan.
Kudo-Asabe Y; Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, 1- 1-1 Hondo, Akita-shi, Akita, 010-8543, Japan.
Nishida A; Department of Pathology, Nihonkai General Hospital, Sakata, Japan.
Otsuka N; Department of Surgery, Noshiro Yamamoto Medical Association Hospital, Noshiro, Japan.
Yasui O; Department of Surgery, Noshiro Yamamoto Medical Association Hospital, Noshiro, Japan.
Kato I; Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Fukushima N; Department of Pathology, Jichi Medical University, Shimotsuke, Japan.
Goto A; Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, 1- 1-1 Hondo, Akita-shi, Akita, 010-8543, Japan.; Pokaż więcej
Źródło:: Diagnostic pathology [Diagn Pathol] 2024 Apr 15; Vol. 19 (1), pp. 59. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Perivascular Epithelioid Cell Neoplasms*/surgery
Perivascular Epithelioid Cell Neoplasms*/pathology
Kidney Neoplasms*
Leukemia, Myeloid, Acute*
Male ; Female ; Humans ; Aged ; Biomarkers, Tumor ; Immunohistochemistry ; Pancreas/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 54.

Tytuł:: CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer.
Autorzy:: Yang K; Department of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China.
Ma Y; Department of Gynecology and Obstetrics, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China.
Chen W; Department of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China.
Liu L; College of Life Sciences, Northwest University, Xi'an, 710000, China.
Yang Z; Department of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China.
He C; Department of Oncology, The First Affiliated Hospital of Shanxi Medical University, Taiyuan, 030000, China.
Zheng N; Department of General Surgery, The First Affiliated Hospital of Jiamusi University, Jiamusi, 154002, China.
Liu X; Department of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China.
Cheng X; Department of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China.
Song J; Department of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China.
Chen Y; Department of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China. .
Qiao H; Department of Pediatrics, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China. .
Zhang R; Department of Hepatobiliary Surgery, Xi Jing Hospital, Air Force Medical University, Xi'an, 710032, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 13; Vol. 14 (1), pp. 8575. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*
Liver Neoplasms*
Humans ; Prognosis ; Genomics ; Biomarkers, Tumor/genetics ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 55.

Tytuł:: Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Autorzy:: Zhu W; Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Wang W; Department of General Surgery, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510630, China.
Zheng W; Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Chen X; Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Wang X; Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Xie J; Department of General Surgery, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, 518000, China.
Jiang S; Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Chen H; Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Zhu S; Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.; Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Xue P; Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510630, China.
Jiang X; Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510630, China. .
Li H; Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China. .
Wang G; State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou, 510630, China. .; Department of Liver Transplantation, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510630, China. .; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510630, China. .; Chinese Medicine Guangdong Laboratory (Hengqin Laboratory), Hengqin, 519031, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 10; Vol. 14 (1), pp. 8416. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:: Observational Study; Multicenter Study; Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnosis
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Protein Precursors*
Humans ; Retrospective Studies ; alpha-Fetoproteins/metabolism ; Biomarkers ; Prothrombin ; Biomarkers, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 56.

Tytuł:: KMT2C mutation as a predictor of immunotherapeutic efficacy in colorectal cancer.
Autorzy:: Ni C; Department of Gastrointestinal Surgery, Nanjing Jiangning Hospital of Chinese Medicine, Nanjing, China.
Wang X; Department of General Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Liu S; Department of Oncology, Jiangyin People's Hospital, Jiangyin, China.
Zhang J; The Medical Department, 3D Medicines Inc, Shanghai, China.
Luo Z; Department of Digestive Disease, Huashan Hospital, Fudan University, Shanghai, 200040, China. .
Xu B; Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 09; Vol. 14 (1), pp. 8284. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/therapy
Humans ; Mutation ; Biomarkers ; Immunotherapy ; Biomarkers, Tumor/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 57.

Tytuł:: Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient.
Autorzy:: Bhaskari J; Department of Biochemistry, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.; National Centre for Biological Sciences, GKVK campus, Bangalore, Karnataka, India.
Bhagat R; Department of Biochemistry, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.; Oncostem Diagnostic Pvt Ltd, Bangalore, Karnataka, India.
Shilpa V; Department of Biochemistry, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.; Department of Biochemistry, Sri Shankara Cancer Hospital and Research Centre, Bangalore, 560004, Karnataka, India.
Premalata CS; Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
Krishnamoorthy L; Department of Biochemistry, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India. .; Department of Biochemistry, Sri Shankara Cancer Hospital and Research Centre, Bangalore, 560004, Karnataka, India. .; Pokaż więcej
Źródło:: Journal of ovarian research [J Ovarian Res] 2024 Apr 09; Vol. 17 (1), pp. 77. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Ovarian Neoplasms*/pathology
Humans ; Female ; Carcinoma, Ovarian Epithelial/pathology ; Prognosis ; Cyclooxygenase 2/metabolism ; Vascular Endothelial Growth Factor C ; Ki-67 Antigen ; Nitric Oxide ; Neoplasm Staging ; Biomarkers, Tumor/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 58.

Tytuł:: Correlation between spleen density and prognostic outcomes in patients with colorectal cancer after curative resection.
Autorzy:: Xiao Y; Department of Radiology, PingYang People's Hospital, Wenzhou Medical University, Wenzhou, 325400, China.
Wen X; Department of Obstetrics, PingYang People's Hospital, Wenzhou Medical University, Wenzhou, 325400, China.
Ying Y; Department of Radiology, PingYang People's Hospital, Wenzhou Medical University, Wenzhou, 325400, China.
Zhang X; Department of Radiology, PingYang People's Hospital, Wenzhou Medical University, Wenzhou, 325400, China.
Li L; Department of Radiology, PingYang People's Hospital, Wenzhou Medical University, Wenzhou, 325400, China.
Wang Z; Department of Radiology, PingYang People's Hospital, Wenzhou Medical University, Wenzhou, 325400, China.
Su M; Department of Radiology, PingYang People's Hospital, Wenzhou Medical University, Wenzhou, 325400, China. .
Miao S; Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Apr 06; Vol. 24 (1), pp. 425. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:: Journal Article
MeSH Terms:: Spleen*/diagnostic imaging
Spleen*/surgery
Spleen*/pathology
Colorectal Neoplasms*/pathology
Humans ; Prognosis ; Neoplasm Staging ; Retrospective Studies ; Nomograms ; Biomarkers, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 59.

Tytuł:: Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
Autorzy:: Zhang C; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang , China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.
Xu X; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang , China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.
Wang T; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Lu Y; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Lu Z; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Wang T; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Pan Z; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang , China. pan_.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China. pan_.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 04; Vol. 14 (1), pp. 7941. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:: Journal Article
MeSH Terms:: Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Carcinoma, Transitional Cell*/pathology
Humans ; Urinary Bladder/pathology ; Vimentin/genetics ; Biomarkers, Tumor/metabolism ; DNA Methylation/genetics ; Nuclear Proteins/genetics ; Twist-Related Protein 1/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 60.

Tytuł:: High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
Autorzy:: Han H; Department of Thoracic Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Huang H; Department of Thoracic Surgery, People's Hospital of Dongxihu District, Wuhan, Hubei, China.
Chen AP; Department of Thoracic Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Tang Y; Department of Thoracic Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Huang X; Department of Thoracic Surgery, People's Hospital of Dongxihu District, Wuhan, Hubei, China.
Chen C; Department of Thoracic Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 04; Vol. 19 (4), pp. e0292726. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Neoplasms*/pathology
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Humans ; Prognosis ; Proportional Hazards Models ; Disease-Free Survival ; Biomarkers, Tumor/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Biomarkers, Tumor"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język